SCHEMBL21739100

SCHEMBL21739100

Cc1cccc2cc(C(=O)NS)[nH]c12

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 3/20 0.68
SMYD3 Q9H7B4 2/20 0.62
SETD2 Q9BYW2 3/20 0.57
HRH4 Q9H3N8 6/20 0.53
DAO P14920 1/20 0.50
DDO Q99489 1/20 0.50
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
NPC1 O15118 2/20 0.45
MAPT P10636 2/20 0.45
MAPK1 P28482 2/20 0.45
RAB9A P51151 2/20 0.45
KDM4E B2RXH2 3/20 0.44
HSD17B10 Q99714 2/20 0.44
THRB P10828 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24019706 0.82 NSD2 (0.64) NSD2SMYD3SETD2HRH4DAO
SCHEMBL26098927 0.81 NSD2 (1.00) NSD2SMYD3SETD2HRH4NPC1
SCHEMBL18354217 0.80 NSD2 (0.61) NSD2SMYD3SETD2HRH4DAO
SCHEMBL2042234 0.80 NSD2 (0.66) NSD2SMYD3SETD2HRH4DAO
SCHEMBL3283667 0.79 NSD2 (0.61) NSD2SMYD3SETD2HRH4DAO
SCHEMBL28399059 0.79 NSD2 (0.60) NSD2SMYD3SETD2HRH4DAO
SCHEMBL29609758 0.79 NSD2 (0.60) NSD2SMYD3SETD2HRH4DAO
SCHEMBL21739507 0.79 NSD2 (0.60) NSD2SMYD3SETD2HRH4DAO
SCHEMBL25040319 0.78 SMYD3 (0.80) NSD2SMYD3SETD2HRH4HDAC3
SCHEMBL25037859 0.78 SMYD3 (0.80) NSD2SMYD3SETD2HRH4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022261243-A1 COMBINATION THERAPIES WITH SETD2 INHIBITORS Epizyme, Inc. (US) 2022-12-15 WO disclosed
WO-2020112872-A1 METHODS OF TREATING WHSC1-OVEREXPRESSING CANCERS BY INHIBITING SETD2 Epizyme, Inc. (US) 2020-06-04 WO disclosed
WO-2020037079-A1 SUBSTITUTED INDOLES AND METHODS OF USE THEREOF Epizyme, Inc. (US) 2020-02-20 WO disclosed